Clinical Trials Directory

Trials / Completed

CompletedNCT03780335

Early Prediction of QFR in STEMI-I

EARLY Microvascular Dysfunction Prediction Using Quantitative Flow Ratio After ST-segment Elevation MYOcardial Infarction (EARLY-MYO-QFR I)

Status
Completed
Phase
Study type
Observational
Enrollment
162 (actual)
Sponsor
RenJi Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The study intends to provide important data on whether the noval method using quantitative flow ratio could predict microvascular dysfunction.

Detailed description

Microvascular dysfunction (MVD) is a serious complication of PCI, which happens frequently after STEMI and always correlates with a poor prognosis. However, precise and simplified assessment of MVD is difficult, especially in the acute phase of STEMI patients. Resent studies suggested that FFR could be overestimated when MVD exists. But whether the overestimated value of FFR caused by CMR defined MVO could reflect microcirculation function is still unclear. This study is a retrospective study using STEMI patients with TFG 2/3 of the infarct vessel on initial angiography and presumed culprit lesion ≥50% as the population. Contrast-enhanced CMR was performed 5 days after PCI as the reference standard.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTComputation of quantitative flow ratioComputation of QFR was performed offline, using AngioPlus system(Pluse medical imaging technology, Shanghai, China). In the first step, 2 diagnostic angiographic projections before PCI, at least 25° apart, were selected and 3D reconstruction of the interrogated vessel without its side branches was performed. Then, the software computed the QFR.

Timeline

Start date
2015-01-01
Primary completion
2018-09-25
Completion
2018-09-30
First posted
2018-12-19
Last updated
2020-04-10

Source: ClinicalTrials.gov record NCT03780335. Inclusion in this directory is not an endorsement.